Stonepine Capital Management, LLC
Top Portfolio Positions
69 positions ·
$379,993,799 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| RADX |
Radiopharm Theranostics Ltd
Healthcare
|
51,000,000 | $219,300,000 | 57.71% | |
| TENX |
Tenax Therapeutics, Inc.
Healthcare
|
1,950,400 | $31,186,896 | 8.21% | |
| VSTM |
Verastem, Inc.
Healthcare
|
3,302,300 | $17,502,190 | 4.61% | |
| ADMA |
Adma Biologics, Inc.
Healthcare
|
1,890,000 | $17,028,900 | 4.48% | |
| EOLS |
Evolus, Inc.
Healthcare
|
2,179,091 | $8,956,064 | 2.36% | |
| CAMP |
Camp4 Therapeutics Corp
Healthcare
|
1,389,622 | $6,128,233 | 1.61% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
85,000 | $6,115,750 | 1.61% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
100,000 | $5,272,000 | 1.39% | |
| ZVRA |
Zevra Therapeutics, Inc.
Healthcare
|
480,000 | $4,473,600 | 1.18% | |
| ABEO |
Abeona Therapeutics Inc.
Healthcare
|
846,587 | $3,792,709 | 1.00% |
Portfolio Trend
25 quarters · across all stocks
Holdings in OVID
Shares Held
Position Value (USD)
9 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $88,800 | 40,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $166,858 | 102,367 | Shares | Sole | 2026-02-13 | |
| 2022-09-30 | $2,834,834 | 1,540,671 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $7,499,045 | 3,487,928 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $13,244,736 | 4,218,069 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $12,859,853 | 4,006,185 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $10,929,717 | 3,252,892 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,820,000 | 2,000,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $9,981,897 | 2,483,059 | Shares | Sole | 2021-05-14 | |
| No 13F history on record for this holder in this stock. | ||||||